3rd Annual Cell Culture & Bioprocessing Congress
17th & 18th Nov 2014, London
Over 170 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production
4 interactive streams:
- Cell Line Development: Novel Tools and Techniques
- Process Development: Upstream and Downstream Process Optimisation
- Cell Line Development: Ensuring Stability and Quality of Cell Lines
- Biological Production: Manufacturing and Cell Banking Case Studies
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Building on the success of last year’s event, Oxford Global Conferences are proud to present the 3rd Annual Cell Culture and Bioprocessing Congress, taking place on the 17th and 18th of November 2014 in London. This Congress is an executive platform for over 170 experts working in cell line development, cell line engineering, up and downstream operations, fermentation and biologics production.
A huge increase in global demand for biopharmaceutical products has increased the value of the cell culture industry significantly in the past few years; it is poised to reach a worth of over $6 billion by 2018. This Congress brings together leading experts to discuss ways to support this growth and overcome industry-wide challenges, and will be supported by key industry solution providers like Merck Millipore, Eppendorf, UPM, Solentim and Hamilton. Problems to be discussed include cell line stability, cell line authentication, scale-up improvements, contamination control and increasing reliability and consistency between batches.
On Day One, our panel of experts will discuss the latest advances in cell line and process development. Topics will include transfection of primary and hard-to-transfect cells, novel tools for 3D cell culture, new technologies for media optimization, high throughput cell culture techniques, achieving high titre cell cultures, disposable technology and automated cell line processes.
Day Two of the event will include case studies covering the most important challenges in biological production. Presentations will address how to develop commercially suitable cell banks, improve manufacturing flexibility, standardize single-use technology, ensure successful technology transfer and optimise cell lines for manufacturing. Our panel of industry leaders will also discuss key advances in cell line development, including the genetic characterisation of cell lines using NGS, cell line authentication technologies, contamination prevention methods and innovative cell culture assays.
The 3rd Annual Cell Culture & Bioprocessing Congress forms part of Oxford Global’s highly successful Biologics Series. Upcoming events in the series include:
Agenda
The Event
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.
Day 1 Stream 1
Cell Line Development
- Transfection of primary and hard-to-transfect cells
- Novel tools for 3D cell culture
- New technologies for media optimization
- Stem cell mixture purification
- High-throughput cell culture techniques
- Successful fermentation methods
Day 1 Stream 2
Process Development
- Increasing the efficiency of upstream processes
- Integrating upstream and downstream processing
- Novel downstream processing platforms
- High-titre cell culture processes
- Process development case studies:
- Scale-up improvements
- Disposable bioreactors
- Automated cell line processes
Day 2 Stream 1
Cell Line Development
- Cell line characterisation using NGS
- Cell line engineering for high expression levels
- Cell line selection
- Technologies for cell line authentication
- Methods for preventing contamination
- Techniques to improve the stability of cell lines
- Advanced cell culture assays
Day 2 Stream 2
Biological Production
- Bio-manufacturing case studies:
- Gene therapies
- Viral vaccines
- Monoclonal antibodies
- Developing commercially suitable cell banks
- Improving manufacturing flexibility
- Standardization of single-use technology
- Ensuring successful technology transfer and process validation
- Optimizing cell lines for manufacturing
Contact Oxford Global
Part 1st Floor
Godstow Court
Minns Business Park
Botley
Oxford
OX2 0JB
All general enquiries
Tel: +44 (0)1865 248455
Fax: +44 (0)1865 250985